Ancora Advisors’s Viemed Healthcare VMD Stock Holding History

Ancora Advisors’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.4K	Sell	1,343 -24,711	-95%	-$206K	﹤0.01%	1720
2025 Q4	$194K	Buy	+26,054	New	+$179K	﹤0.01%	747
2023 Q2	–	Sell	-19,905	Closed	-$192K	–	1924
2023 Q1	$192K	Sell	19,905 -44,490	-69%	-$388K	0.01%	652
2022 Q4	$487K	Sell	64,395 -11,796	-15%	-$79.9K	0.01%	497
2022 Q3	$457K	Sell	76,191 -61,729	-45%	-$396K	0.01%	522
2022 Q2	$743K	Hold	137,920	–	–	0.02%	433
2022 Q1	$687K	Buy	137,920 +46,464	+51%	+$216K	0.02%	467
2021 Q4	$478K	Buy	+91,456	New	+$510K	0.01%	567

Other funds holding VMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Ancora Advisors's VMD Position: Q1 2026 in Review

Ancora Advisors reduced its Viemed Healthcare (VMD) stake by 95% in Q1 2026, selling an estimated $206K and leaving 1,343 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1720.

Ancora Advisors first reported a position in VMD in Q4 2021 and has held it in 8 quarters since. The position peaked at $743K in Q2 2022. 149 funds tracked by Wall St. Rank hold VMD as of Q1 2026.

Ancora Advisors held 1,343 shares of Viemed Healthcare worth $12.4K as of Q1 2026.
Ancora Advisors sold 24,711 Viemed Healthcare shares in Q1 2026, an estimated $206K.
Viemed Healthcare made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #1720 holding.
Ancora Advisors first reported a position in Viemed Healthcare in Q4 2021 and has held it in 8 quarters since.
Ancora Advisors's Viemed Healthcare position peaked at $743K in Q2 2022.
149 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.